Tesla’s strategic pivot toward AI and autonomy reinforces its position as a leading disruptive technology company, not merely an automaker, the analysts said. Investors are closely watching regulatory ...
Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...
Despite recent gains, analysts remain divided. Firms like Mizuho and Royal Bank of Canada have adopted more cautious tones, even as others, such as Bank of America, have raised their price targets to ...
On Friday, Wedbush Securities sustained its optimistic stance on Tesla (NASDAQ:TSLA), maintaining an Outperform rating and a $400.00 price target for the electric vehicle and clean energy company.
On Friday, Wedbush Securities sustained its optimistic stance on Tesla (NASDAQ:TSLA), maintaining an Outperform rating and a $400.00 price target for the electric vehicle and clean energy company.